These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 24674763)

  • 1. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea.
    Buendgens L; Bruensing J; Matthes M; Dückers H; Luedde T; Trautwein C; Tacke F; Koch A
    J Crit Care; 2014 Aug; 29(4):696.e11-5. PubMed ID: 24674763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
    Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
    Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-evaluating the Utility of Stress Ulcer Prophylaxis in the Critically Ill Patient: A Clinical Scenario-Based Meta-Analysis.
    Reynolds PM; MacLaren R
    Pharmacotherapy; 2019 Mar; 39(3):408-420. PubMed ID: 30101529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center.
    McCaleb RV; Gandhi AS; Clark SM; Clemmons AB
    Ann Pharmacother; 2016 Jul; 50(7):541-7. PubMed ID: 27091869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
    MacLaren R; Reynolds PM; Allen RR
    JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol.
    Young PJ; Bagshaw SM; Forbes A; Nichol A; Wright SE; Bellomo R; Bailey MJ; Beasley RW; Eastwood GM; Festa M; Gattas D; van Haren F; Litton E; Mouncey PR; Navarra L; Pilcher D; Mackle DM; McArthur CJ; McGuinness SP; Saxena MK; Webb S; Rowan KM;
    Crit Care Resusc; 2018 Sep; 20(3):182-189. PubMed ID: 30153780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.
    Barletta JF; Sclar DA
    Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the ICU.
    Boyd C; Hassig T; MacLaren R
    Pharmacotherapy; 2021 Oct; 41(10):820-827. PubMed ID: 34478588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.
    Kim YG; Graham DY; Jang BI
    J Clin Gastroenterol; 2012; 46(5):397-400. PubMed ID: 22298089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of Histamine
    Hammond DA; Kathe N; Shah A; Martin BC
    Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumonia prevention in intubated patients given sucralfate versus proton-pump inhibitors and/or histamine II receptor blockers.
    Grindlinger GA; Cairo SB; Duperre CB
    J Surg Res; 2016 Dec; 206(2):398-404. PubMed ID: 27884335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.
    Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Møller MH;
    Trials; 2016 Apr; 17(1):205. PubMed ID: 27093939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile infection in an urban medical center: five-year analysis of infection rates among adult admissions and association with the use of proton pump inhibitors.
    Jayatilaka S; Shakov R; Eddi R; Bakaj G; Baddoura WJ; DeBari VA
    Ann Clin Lab Sci; 2007; 37(3):241-7. PubMed ID: 17709687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of stress-related ulcer bleeding at the intensive care unit: Risks and benefits of stress ulcer prophylaxis.
    Buendgens L; Koch A; Tacke F
    World J Crit Care Med; 2016 Feb; 5(1):57-64. PubMed ID: 26855894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
    Aseeri M; Schroeder T; Kramer J; Zackula R
    Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients.
    Ro Y; Eun CS; Kim HS; Kim JY; Byun YJ; Yoo KS; Han DS
    Gut Liver; 2016 Jul; 10(4):581-6. PubMed ID: 27021503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton-pump inhibitors and the risk of Clostridium difficile-associated diarrhea in high-risk antibiotics users: A population-based case-crossover study.
    Hong SH; Lee EK; Shin JY
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):479-488. PubMed ID: 30848536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress Ulcer Prophylaxis in Critically Ill Children: A Multicenter Observational Study.
    Duffett M; Chan A; Closs J; McGloin R; McKelvie G; Pong S; Seto W; Slaney H; Vaninetti G; Vanniyasingam T
    Pediatr Crit Care Med; 2020 Feb; 21(2):e107-e113. PubMed ID: 31821206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological interventions for stress ulcer prophylaxis in critically ill patients: a mixed treatment comparison network meta-analysis and a recursive cumulative meta-analysis.
    Sridharan K; Sivaramakrishnan G; Gnanaraj J
    Expert Opin Pharmacother; 2018 Feb; 19(2):151-158. PubMed ID: 29271262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withholding Pantoprazole for Stress Ulcer Prophylaxis in Critically Ill Patients: A Pilot Randomized Clinical Trial and Meta-Analysis.
    Alhazzani W; Guyatt G; Alshahrani M; Deane AM; Marshall JC; Hall R; Muscedere J; English SW; Lauzier F; Thabane L; Arabi YM; Karachi T; Rochwerg B; Finfer S; Daneman N; Alshamsi F; Zytaruk N; Heel-Ansdell D; Cook D;
    Crit Care Med; 2017 Jul; 45(7):1121-1129. PubMed ID: 28459708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.